Sign In
test

Marco Weibel

Nextech Invest, Ltd.

Assets Managed
$1.421B
Holdings
17
Last Quarter
2026 - Q1
Filed Date
1d ago
Growth Rate
37.38%(2Q avg: 47.42%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Nextech Invest, Ltd.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 17 positions.

Assets under management

The assets under management (AUM) of Nextech Invest, Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.421B in assets, with a quarterly growth rate of 37.38% and a 2-quarter average growth rate of 47.42%. The portfolio is managed by Marco Weibel, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
RVMD
Revolution Medicines Inc
Recent Activity
52.02%
$739.206M
7.601M shares@ $97.26 avg price
TYRA
Tyra Biosciences Inc
Recent Activity
10.94%
$155.339M
4.056M shares@ $38.3 avg price
TNGX
Tango Therapeutics Inc
Recent Activity
10.7%
$152.006M
7.266M shares@ $20.93 avg price
ORIC
Oric Pharmaceuticals Inc
Recent Activity
6.39%
$90.751M
7.163M shares@ $12.68 avg price
ALMS
Alumis Inc
Recent Activity
Increased 21.44%
5.49%
$78.008M
3.541M shares@ $22.04 avg price
RLAY
Relay Therapeutics Inc
Recent Activity
Increased 17.55%
3.87%
$54.989M
5.527M shares@ $9.96 avg price
ZYME
Zymeworks Inc
Recent Activity
1.97%
$27.893M
1.114M shares@ $25.05 avg price
KYMR
Kymera Therapeutics Inc
Recent Activity
1.64%
$23.229M
278,896 shares@ $83.3 avg price
CTMX
Cytomx Therapeutics Inc
Recent Activity
New Position
1.48%
$20.915M
4.45M shares@ $4.7 avg price
CNTX
Context Therapeutics Inc
Recent Activity
1.37%
$19.439M
7.419M shares@ $2.62 avg price

1-10 of 17